Drug intelligence / Profile preview

propofol + clonidine

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Intravenous
01

Overview

Propofol + clonidine is a combination of two drugs used primarily in anesthesia and procedural sedation. Propofol is an intravenous anesthetic agent that acts mainly as a positive allosteric modulator of the gamma-aminobutyric acid type A (GABA-A) receptor, leading to central nervous system depression and rapid induction of unconsciousness. Clonidine is an alpha-2 adrenergic receptor agonist with sedative, analgesic, and antihypertensive properties; it reduces sympathetic outflow from the central nervous system. When used together, clonidine enhances the sedative effects of propofol, allowing for reduced propofol dosage requirements while maintaining effective anesthesia or sedation. This combination has been shown to provide faster onset of sedation, improved patient satisfaction, deeper levels of sedation, and greater hemodynamic stability compared to propofol alone; however, it may also prolong recovery times[1][2][5][6][8]. The mixture can be physically compatible for co-administration under certain conditions[4].

02

Targets

ADRA2A (α2A)GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on propofol + clonidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on propofol + clonidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call